Research Frontiers Incorporated
REFR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $359 | $130 | $560 | $178 |
| % Growth | 176.7% | -76.8% | 214.2% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $359 | $130 | $560 | $178 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $142 | $169 | $163 | $160 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $522 | $776 | $636 | $642 |
| Operating Expenses | $663 | $945 | $799 | $802 |
| Operating Income | -$304 | -$815 | -$240 | -$624 |
| % Margin | -84.6% | -627.5% | -42.8% | -350.4% |
| Other Income/Exp. Net | $5 | $11 | $62 | $16 |
| Pre-Tax Income | -$299 | -$804 | -$178 | -$608 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$299 | -$804 | -$178 | -$608 |
| % Margin | -83% | -618.8% | -31.7% | -341.2% |
| EPS | -0.01 | -0.024 | -0.005 | 0.021 |
| % Growth | 58.2% | -350.9% | -125.2% | – |
| EPS Diluted | -0.01 | -0.024 | -0.005 | 0.021 |
| Weighted Avg Shares Out | 33,648 | 33,648 | 33,648 | 33,521 |
| Weighted Avg Shares Out Dil | 33,648 | 33,648 | 33,648 | 33,521 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5 | $11 | $15 | $16 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $47 | $47 | $46 | $137 |
| EBITDA | -$252 | -$768 | -$193 | -$488 |
| % Margin | -70% | -591.5% | -34.5% | -273.7% |